Population
Vascular smooth muscle cells (VSMC A-10)
Comparison
Angiotensin II pretreatment, with or without… vs Untreated cells or cells without specific…
Design
Preclinical
Authors
Loading...
Suggests PKC role in AII-ANF signaling in animal VSMCs; hypothesis-generating and leaves open relevance to human hypertension.
Angiotensin II modulates ANF-R2 receptor-mediated inhibition of adenylyl cyclase in vascular smooth muscle cells via PKC-mediated uncoupling from Gi protein.
Anuradha Palaparti (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: